There are multiple further licensing deals tracking towards finalization. I understand we should see further Zolpi deals soonish + potential news of the AritiMist sale. In addition to Zolpi and ArtiMist there will be other news prior to end of Nov regarding SUD-003. Having the Eddingpharm deal now in place for Zolpi sets the benchmark T&C's which is likely to expedite future deal flow for this product. DYOR
$34 mil over the next 15 yrs in royalties, page-19
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $168.2M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.5¢ | 15.5¢ | $219.4K | 1.389M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11000 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 807231 | 11 |
View Market Depth
| Last trade - 12.31pm 01/10/2024 (20 minute delay) ? |
| ALA (ASX) Chart |